Caribou Biosciences Inc (CRBU) Stock Price, Quote, News & History

CRBUNASDAQ
$2.48
0.125.07%
Last update: Jun 1, 10:14 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-101.25M
Investing Cash Flow (TTM)
76.84M
Financing Cash Flow (TTM)
7.05M
Free Cash Flow (TTM)
-101.64M
Capital Expenditure (TTM)
-389.00K
Net Change in Cash (TTM)
-17.36M

Analyst Trends and Forecast

1
Feb
1
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$143.39M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
19.84
PB Ratio (TTM)
2.29
Earnings Yield % (TTM)
-60.17%
Earnings Yield % (FWD)
-48.73%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.03

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$12.06M
Debt to Equity
0.26
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.35
Close
-
Volume / Avg.
569.51K / 1.42M
Day Range
$2.31 - $2.49
52 Wk Range
0.96 - 3.54
Market Cap
$245.93M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
69
Short Interest
7.49%
Days to Cover
4.52

About

Sector
Health Care
Industry
Biotechnology
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The compa...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Caribou Biosciences (CRBU) stock?

A

You can purchase shares of Caribou Biosciences (NASDAQ:CRBU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Caribou Biosciences (CRBU) competitors?

A

There are no as such competitors for Caribou Biosciences.

Q

What is the forecast, or price target, for Caribou Biosciences (CRBU) stock?

A

Caribou Biosciences has a consensus price target of $12.71.

Q

What is the current price for Caribou Biosciences (CRBU)?

A

The stock price for Caribou Biosciences (NASDAQ: CRBU) is $2.4796 last updated June 1, 2026 at 10:14 AM EDT.

Q

Does Caribou Biosciences (CRBU) pay a dividend?

A

There are no upcoming dividends for Caribou Biosciences.

Q

When is Caribou Biosciences (NASDAQ:CRBU) reporting earnings?

A

Caribou Biosciences does not have any upcoming earnings scheduled.

Q

Is Caribou Biosciences (CRBU) going to split?

A

There is no upcoming split for Caribou Biosciences.

Q

What sector and industry does Caribou Biosciences (CRBU) operate in?

A

Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.